1. Home
  2. TPCS vs CRIS Comparison

TPCS vs CRIS Comparison

Compare TPCS & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TechPrecision Corporation

TPCS

TechPrecision Corporation

N/A

Current Price

$5.73

Market Cap

45.1M

Sector

Industrials

ML Signal

N/A

Logo Curis Inc.

CRIS

Curis Inc.

N/A

Current Price

$1.54

Market Cap

20.6M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TPCS
CRIS
Founded
1956
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
45.1M
20.6M
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
TPCS
CRIS
Price
$5.73
$1.54
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
52.3K
267.6K
Earning Date
02-17-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
41.38
91.57
EPS
N/A
N/A
Revenue
$31,644,000.00
$9,898,000.00
Revenue This Year
N/A
$27.10
Revenue Next Year
N/A
$67.74
P/E Ratio
N/A
N/A
Revenue Growth
N/A
31.50
52 Week Low
$2.88
$0.18
52 Week High
$6.31
$6.74

Technical Indicators

Market Signals
Indicator
TPCS
CRIS
Relative Strength Index (RSI) 63.51 28.49
Support Level $4.41 $1.54
Resistance Level $6.31 $5.55
Average True Range (ATR) 0.27 0.35
MACD 0.03 -0.16
Stochastic Oscillator 63.98 3.16

Price Performance

Historical Comparison
TPCS
CRIS

About TPCS TechPrecision Corporation

Techprecision Corp manufactures precision, large-scale fabricated and machined metal structural components and systems. The company provides end-to-end services, transforming raw materials into precision finished products through custom fabrication, precision machining, assembly, integration, inspection, non-destructive evaluation, and testing. It manufactures products in accordance with customers' drawings and specifications while complying with applicable national and international industry codes and standards. Its segments are: Ranor, which generates the majority of revenue, and Stadco, both focused on the manufacture and assembly of components mainly for defense and other precision industrial customers.

About CRIS Curis Inc.

Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.

Share on Social Networks: